From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves first treatment for chronic rhinosinusitis with nasal polyps

from FDA

The U.S. Food and Drug Administration recently approved Dupixent (dupilumab) to treat adults with nasal polyps accompanied by chronic rhinosinusitis. This is the first treatment approved for inadequately controlled chronic rhinosinusis with nasal polyps. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063